combination of a compound, compound of formula ia or a pharmaceutically acceptable salt thereof, method for treating a braf v600e mutation-modulated disease or disorder and high levels of pakt in a mammal and use

• 收藏
• 分享

专利权人:

GENENTECH; INC

发明人:

KLAUS HOEFLICH,MARK MERCHANT

申请号：

BR112013025386

公开号：

BR112013025386A2

申请日:

2012.03.30

申请国别(地区):

BR

年份:

2017

代理人:

摘要：

The invention provides A combination of, a) a compound of Formula (I) or a pharmaceutically acceptable salt thereof； and b) erlotinib or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/